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Abstract:  As  part  of  our  studies  focused  on  the  design  and  synthesis  of  biologically  active  molecules, 
polyheterocyclic compound 3 was prepared in one step from commercially available 2-aminothiophenol 1 and 
2,5-dihydro-2,5-dimethoxyfuran 2. Derivative  3 underwent a further isomerization to compound 4 in a reaction 
promoted by traces of HCl in chloroform. 
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Introduction   
 
1,4-Benzothiazines  are  known  to  possess  a  wide  spectrum  of  biological  and 
pharmacological activities
1. These compounds have been prepared by a variety of methods
2. 
One of them uses 2-aminothiophenol and different carbonyl derivatives as starting materials 
and it has been studied extensively
3.  The course of the reaction was found to depend on the 
conditions,  as  well  as  the  nature  of  the  carbonyl  derivatives.  Benzothiazoles, 
benzothiazepines, as well as other ring systems have also been obtained by this reaction.
3  
As  part  of  our  studies  focused  on  the  synthesis  of  new  benzothiazines,  we  became 
interested in the new functionalized derivative 5 since both the aldehyde function and the 
secondary amine would be useful handles to prepare chemical libraries starting from such an 
intermediate. Following literature data, this compound should be accessible in principle by 
reaction of 2-aminothiophenol with a 1,4-dialdehyde, such as fumaraldehyde or equivalent 
derivatives (Scheme 1)  Mediterr.J.Chem., 2014, 3(2),  A. Jaafar et al.    832 
 
 
 
 
Scheme 1. Retrosynthetic analysis for compound 5. 
 
Therefore,  we have studied the reaction of 2-aminothiophenol  1 with 2,5-dihydro-2,5-
dimethoxyfuran 2, as precursor (in situ) of the ,-unsaturated dicarbonyl system, namely the 
unstable fumaraldehyde
4 (Scheme 2). 
 
 
Scheme 2. Generation of fumaraldehyde in situ from 2,5-dihydro-2,5-dimethoxyfuran. 
 
Unexpectedly,  the  reaction  did  not  give  the  desired  dihydrobenzothiazine  product  5. 
Instead, it led to the formation of a stable crystalline polycyclic compound 3. The structure 
and  the  stereochemistry  of  compound  3  were  established  using  spectral  techniques  and 
confirmed by X-ray crystallography.
5 To the best of our knowledge, only one example of 
polycyclic compound of this type has been reported to date
6. Further, compound 3, once 
dissolved  in  CHCl3  with  traces  of  acid,  underwent  isomerization  to  a  new 
dihydrobenzothiazine-benzothiazole system 4.  
 
Results and Discussion  
 
Reaction of 2,5-dihydro-2,5-dimethoxyfuran 2 with an excess of 2-aminothiophenol 1 (2.5 
equiv.) in a THF/H2O mixture in the presence of a catalytic amount of conc. H2SO4 at room 
temperature gave the compound 3 in 50% yield, as a crystalline solid (Scheme 3). 
 
 
Scheme 3. Preparation of compound 3. 
 
The same reaction has been performed using dimethyl acetal of fumaraldehyde (another 
precursor of fumaraldehyde) instead of 2, but it resulted in a considerable decrease in the 
yield of compound 3 (15 - 20% yield).   
The structure of compound 3 was established on the basis of extensive 1D- and 2D-NMR 
studies and confirmed by X-ray crystallography (Figure 1). In the 
1H NMR spectrum of 3, the 
triplet at  5.80 ppm (J = 4.9 Hz) has been assigned to the proton H16 and the doublet at  4.91 
ppm (J = 5.7 Hz) assigned to proton H8, the triplet of doublets signal at  3.91 ppm (J = 7.4 
Hz and J’ = 5.7 Hz) attributed to proton H18, the doublet of doublets signal at  2.57 ppm (J = 
7.4 Hz and 4.9 Hz) attributed to the two diastereotopic protons H17 and H17’ which seem to be Mediterr.J.Chem., 2014, 3(2),  A. Jaafar et al.    833 
 
 
 
equivalent because they have similar environment. It is important to note that H8 couples with 
H18  with  a  coupling  constant  J  =  5.7  Hz  which  is  indicative  of  a  cis  relationship.  This 
stereochemical cis relationship between protons H8 and H18 is clearly shown in the X-ray of 
compound 3 (Figure 1). The 
1H NMR spectrum of compound 3 also displayed signals in the 
regions of 6.60-7.20 ppm attributed to the eight protons of the two aromatic rings. 
 
 
Figure 1. a) Structure of compound 3.  b) ORTEP X-ray structure of compound 3. 
 
One interesting feature of this reaction is the stereoselectivity. Compound 3 was isolated as a 
single  diastereoisomer,  and  we  did  not  observe  the  formation  of  another  stereoisomer.  A 
tentative mechanism to explain the formation of compound 3 is shown in Scheme 4. It is 
believed that the first  step involves  a conjugated addition  (Michael  addition) of the  thiol 
function on the fumaraldehyde (generated in situ from the 2,5-dihydro-2,5-dimethoxyfuran) 
followed by an intramolecular condensation that leads to the formation of the benzothiazine 
system. Then, a second molecule of aminothiophenol reacts to give the benzothiazole moiety. 
The scheme is completed by an intramolecular nucleophilic addition of the benzothiazole 
nitrogen atom to afford final compound 3. The transition state leading to a five-membered 
ring C is believed to be responsible for the observed cis stereoselectivity.  
 
Scheme 4. Tentative mechanism for the formation of compound 3. 
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We also noticed that, under the same conditions, compound 2 did not react with either 2-
aminophenol or 1,2-diaminobenzene, which support our proposed mechanism in which the 
sulfur atom (soft nucleophile) adds to fumaraldehyde in a 1,4-fashion. This kind of addition is 
not favoured in case of hard nucleophiles such as NH2 or OH. 
 
Isomerization: 
 
When compound 3 was dissolved in CDCl3 for a routine 
1H NMR experiment, new signals 
for  aromatic  protons  appear  in  the  region    7.30-8.10  ppm  (Figure  2).  We  suspected  a 
transformation (isomerization) of compound 3, promoted by trace amounts of acid found in 
CDCl3, to be taking place in the NMR tube.  
 
 
Figure 2. a) Aromatic region of the 
1H NMR spectrum of compound 3 showing the beginning 
of isomerization to compound 4 taking place in the NMR tube. b) Aromatic regions of 
1H 
NMR spectrum of compound 4 after complete isomerization. 
 
In an attempt to investigate the nature of this transformation, a sample of compound 3 was 
dissolved  in  CHCl3  and  treated  overnight  with  one  drop  of  concentrated  HCl.  Complete 
isomerization to the new compound 4 occurred (Scheme 5).  
 
Scheme 5. Isomerization of compound 3 to compound 4. 
 
The structure of 4 has been proposed based first on the 
1H NMR spectrum which revealed 
the disappearance of the signal of proton H16 at  5.80 ppm and the appearance of new signals 
for  aromatic  protons  in  the  region    7.30-8.10  ppm,  characteristics  for  the  benzothiazole Mediterr.J.Chem., 2014, 3(2),  A. Jaafar et al.    835 
 
 
 
system. Further evidence came from the appearance, in the 
13C NMR spectrum of compound 
4, of a quaternary carbon signal at  167.98 ppm which was assigned to the carbon of C=N. 
Further evidence for the isomerization was indicated by the high resolution mass spectrum 
which supported the same molecular formula of C16H14N2S2 for both compounds 3 and 4. 
The 
1H NMR spectrum of compound 4 also shows many multiplets in the regions of  
6.50-8.10 ppm attributed to the eight protons of the two aromatic rings. These protons can be 
divided into two sets: the four protons of the aromatic ring A appear in the region of  6.50-
7.00 ppm (about the same chemical shifts as in compound 3), and the signals for the four 
protons of aromatic ring E appear at  7.40-8.10 ppm. The 
1H NMR spectrum of compound 4 
also exhibits many signals in the region from 3 to 4 ppm. A signal (dddd, J = 7.6, 6.9, 5.4, and 
2.7 Hz) is seen at  3.84 ppm assigned to H18; this proton is coupled to four different protons, 
the two diastereotopic protons (H8 and H8’) and the two diastereotopic protons (H17 and H17’)  . 
A doublet of doublet signal at  3.71 ppm is attributed to H8 or H8’(J =12.3, 2.7 Hz). Another 
doublet of doublet at  3.56 ppm was assigned to H17 or H17’ (J =15.0,7.6 Hz. A multiplet is 
also seen at  3.44-3.50 ppm and attributed to two protons [H8(8’) and H17(17’)].  Extensive 2D 
NMR experiments (COSY, HMQC, HMBC) have been performed on compound 4 and they 
were  in  agreement  with  the  proposed  structure.  Unfortunately,  all  our  attempts  to  obtain 
single crystals suitable for X-ray analysis failed. 
 
A tentative mechanism to explain the acid-catalyzed isomerization is shown in scheme 6, 
and is believed to be driven by the aromatization of the thiazole ring.  
 
 
Scheme 6: Proposed mechanism for the isomerisation of compound 3 to compound 4 
 
The fact that isomerization 3 to 4 did not take place in the reaction medium (a THF/H2O 
mixture) can be attributed to the low solubility of compound 3 in that medium. It is also 
important  to  note  that  compound  3  was  isolated  after  24  hours  of  reaction  in  THF/H2O 
mixture whereas isomerization to compound 4 was complete within few hours in chloroform. 
 
Conclusion 
 
In summary we have described a simple method for the preparation of new polycyclic 
compounds 3 and 4 which could be of interest in medicinal chemistry. Compound 4 merit 
special attention since it combines in its structure the two moieties of dihydrobenzothiazine 
and benzothiazole, which are both recognized as related to a broad range of bioactivities
1,7. Mediterr.J.Chem., 2014, 3(2),  A. Jaafar et al.    836 
 
 
 
Further  studies  are  currently  underway  to  extend  this  method  to  prepare  differently 
substituted polycyclic compounds starting from suitably substituted aminothiophenols. 
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Experimental Section  
 
The melting points were determined using system Kofler.
1H NMR spectra were recorded 
at  300  MHz. 
13C  NMR  spectra  were  recorded  at  75  MHz.  Column  chromatography  was 
performed on silica gel, particle size (40-63µm). 
 
Preparation of compound 3: To a solution of 2,5-dihydro-2,5-dimethoxyfuran (100 mg, 0.78 
mmol) in THF (5 mL) and H2O (10 mL) was added 2-aminothiophenol (250 mg, 2.0 mmol, 
2.5 equiv.). A drop of concentrated H2SO4 was added and the reaction mixture was stirred 
overnight at room temperature. The reaction mixture was then neutralized with a solution of 
Na2CO3  and  extracted  with  ethyl  acetate  (3x10  mL)  and  dried  over  anhydrous  Na2SO4. 
Removal of the solvent under reduced pressure gave a  yellow oil which was purified by 
column  chromatography  using  hexane-ethyl  acetate  (98:2)  as  eluent  to  give  the  title 
compound 3 (114 mg, 50% yield) as a yellowish solid. mp 152-153
oC. 
1H NMR(CDCl3, 300 
MHz):  (ppm)  7.16 (dd; J = 7.71, 1.43 Hz; 1H); 7.12 (dd; J = 7.52, 1.30 Hz; 1H); 7.06      
(td; J = 7.76, 1.48 Hz; 1H); 7.01 (dd; J = 7.59, 1.41 Hz; 1H);  6.94 (dd; J = 7.51, 1.32 Hz; 
1H);  6.88 (dd; J = 7.66, 1.22 Hz; 1H); 6.78 (td; J = 7.54, 1.23 Hz; 1H); 6.69 (dd; J = 7.93, 
1.18 Hz; 1H); 5.81 (t; J = 4.89 Hz; 1H); 4.91 (d; J = 5.68 Hz; 1H); 3.91 (td; J = 7.42, 5.70 Hz; 
1H); 2.57 (dd; J = 7.41, 4.90 Hz; 2H).
13C NMR (CDCl3, 75 MHz): 147.53(C10); 140.95(C6); 
132.61(C15) ;  116.46(C1) ;  128.13,  126.61,  125.34,  123.92,  121.93,  119.71,  115.92,  and 
114.97 (C2, C3, C4, C5, C11, C12, C13, and C14); 78.76 (CH, C8); 71.27 (CH, C16); 40.52 (CH, 
C18); 39.58  (CH2, C17). HRMS (ESI): C16H14N2NaS2, [M+Na]
+ calcd: 321.04961; found: 
321.0494. 
 
Preparation of compound 4: To a solution of 3 (100 mg, 0.34 mmol) in CHCl3 (10  mL) was 
added one drop of conc. HCl. The reaction mixture was stirred at room temperature overnight.  
The  reaction  mixture  was  then  washed  with  water  (3x  5mL)  and  dried  over  anhydrous 
Na2SO4.  Removal  of  the  solvent  under  reduced  pressure  gave  a  yellow  solid  which  was 
purified  by  column  chromatography  using  hexane-ethyl  acetate  (95:5)  as  eluent  to  give 
compound 4 (98 mg, 98% yield) as a yellowish solid. mp 149-151
oC. 
1H NMR(CDCl3, 300 
MHz):  (ppm) ring E [8.01(d; J=7.8 Hz; H11 or H14); 7.86 (d; J=7.8 Hz; H11 or H14); 7.48 (td; 
J=8.11, 1.23 Hz; H12 or H13); 7.38 (td; J=8.12 , 1.53 Hz; H12 or H13)]; ring A [7.00 (dd; J=7.8 
, 1.5 Hz; H2); 6.93(td; J=7.81 J=1.53 Hz; H3); 6.66 (td; J=7.82, 1.22 Hz; H4); 6.52 (dd; J=7.81  
, 1.22 Hz; H5)];  3.84 (H18; dddd; J= 7.61, 6.92, 5.42, and 2.74 Hz); 3.71 (H8(8’); dd,  J=12.32, 
2.74 Hz); 3.56  (H17(17’); dd; J=15.01 and 7.63 Hz); 3.50-3.44 (m; H8(8’) and H17(17’), 2H); 
13C 
NMR (CDCl3, 75 MHz):  167.98 (C16); 153.08(C10); 141.12 (C6), 135.15(C15); and 115.02 
(C1); 127.70, 126.05, 125.47, 125.00, 122.67, 121.50, 118.54, and 115.29 (C2, C3, C4, C5, C11, 
C12,  C13,  and  C14);  45.76  (CH2,  C8);  38.46  (CH,  C18);  38.34  (CH2,  C17).  HRMS  (ESI): 
C16H14N2NaS2, [M+Na]
+ calcd: 321.04961; found: 321.0496. Mediterr.J.Chem., 2014, 3(2),  A. Jaafar et al.    837 
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